US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

Inhalon Biopharma's inhaled RSV antibody treatment will enter human trials marking a potential breakthrough in respiratory ...

Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...

Recent studies have provided valuable insights into the pathophysiology of febrile ... viral infections such as Influenza A and Respiratory Syncytial Virus (RSV)[3]. This seasonal trend ...

Respiratory syncytial virus (RSV). Nemours KidsHealth. Is it a cold, the flu, an RSV infection, or COVID-19? UpToDate. Patient education: bronchiolitis and RSV in infants and children (beyond the ...

The respiratory syncytial virus was the most frequent offender ... A discussion of the various complex factors involved in the pathogenesis of chronic bronchitis is beyond the scope of this ...

COVID-19 and flu activity is increasing in most parts of the country and RSV activity remains very high, especially in young children. Respiratory illness activity in Florida is very high ...

Pfizer and GSK vaccines will now be required to carry warnings that they may be tied to an increased risk of a rare neurological side effect. © 2024 Fortune Media IP ...

Winter is usually accompanied by an uptick in respiratory illnesses, such as Covid-19 and RSV, and 2025 is no exception. For RSV in particular, nearly two dozen states are currently reporting high ...